Stay updated with breaking news from Beckley Psytech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This is the first time the FDA has given IND approval for a Phase IIb study of a short-acting psychedelic like 5-MeO-DMT (Mebufotenin). Beckley Psytech plans to initiate a global multi-site
Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric disorders by transforming psychedelics into safe, effective and licensed medicines, today announced that it had received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration ...
The antipsychotic drugs market is expanding rapidly due to the increasing prevalence of mental disorders such as schizophrenia, schizoaffective disorder,...
The antipsychotic drugs market is expanding rapidly due to the increasing prevalence of mental disorders such as schizophrenia, schizoaffective disorder, bipolar disorder, severe depression
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries The agency regulating all things ...